221 related articles for article (PubMed ID: 33402473)
21. Opisthorchis viverrini: Gene expression profiling of carcinogenic adult liver fluke worms using 5' SAGE.
Chutiwitoonchai N; Shen Y; Zheng H; Xiong H; Zhao G; Imtawil K; Intapan PM; Wongkham S; Wongkham C
Exp Parasitol; 2008 Dec; 120(4):306-13. PubMed ID: 18786530
[TBL] [Abstract][Full Text] [Related]
22. Wound healing and cancer progression in Opisthorchis viverrini associated cholangiocarcinoma.
Botelho MC; Alves H; Richter J
Parasitol Res; 2016 Jul; 115(7):2913-4. PubMed ID: 27130317
[TBL] [Abstract][Full Text] [Related]
23. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.
Kongpetch S; Jusakul A; Lim JQ; Ng CCY; Chan JY; Rajasegaran V; Lim TH; Lim KH; Choo SP; Dima S; Popescu I; Duda DG; Kukongviriyapan V; Khuntikeo N; Pairojkul C; Rozen SG; Tan P; Teh BT
JCO Glob Oncol; 2020 Apr; 6():628-638. PubMed ID: 32315234
[TBL] [Abstract][Full Text] [Related]
24. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
[TBL] [Abstract][Full Text] [Related]
25. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.
Thanee M; Loilome W; Techasen A; Sugihara E; Okazaki S; Abe S; Ueda S; Masuko T; Namwat N; Khuntikeo N; Titapun A; Pairojkul C; Saya H; Yongvanit P
Cancer Sci; 2016 Jul; 107(7):991-1000. PubMed ID: 27176078
[TBL] [Abstract][Full Text] [Related]
26. Discovering proteins for chemoprevention and chemotherapy by curcumin in liver fluke infection-induced bile duct cancer.
Khoontawad J; Intuyod K; Rucksaken R; Hongsrichan N; Pairojkul C; Pinlaor P; Boonmars T; Wongkham C; Jones A; Plieskatt J; Potriquet J; Bethony JM; Mulvenna J; Pinlaor S
PLoS One; 2018; 13(11):e0207405. PubMed ID: 30440021
[TBL] [Abstract][Full Text] [Related]
27. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma.
Saengboonmee C; Seubwai W; Wongkham C; Wongkham S
Cancer Epidemiol; 2015 Jun; 39(3):274-8. PubMed ID: 25910864
[TBL] [Abstract][Full Text] [Related]
28. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
Buisson Y
Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582
[TBL] [Abstract][Full Text] [Related]
29. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
[No Abstract] [Full Text] [Related]
30. Ultrasonography as a tool for monitoring the development and progression of cholangiocarcinoma in Opisthorchis viverrini/ dimethylnitrosamine-induced hamsters.
Plengsuriyakarn T; Eursitthichai V; Labbunruang N; Na-Bangchang K; Tesana S; Aumarm W; Pongpradit A; Viyanant V
Asian Pac J Cancer Prev; 2012; 13(1):87-90. PubMed ID: 22502719
[TBL] [Abstract][Full Text] [Related]
31. Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection.
Songserm N; Prasongwattana J; Sithithaworn P; Sripa B; Pipitkool V
Asian Pac J Cancer Prev; 2009; 10(2):299-302. PubMed ID: 19537899
[TBL] [Abstract][Full Text] [Related]
32. Liver fluke granulin promotes extracellular vesicle-mediated crosstalk and cellular microenvironment conducive to cholangiocarcinoma.
Arunsan P; Chaidee A; Cochran CJ; Mann VH; Tanno T; Kumkhaek C; Smout MJ; Karinshak SE; Rodpai R; Sotillo J; Loukas A; Laha T; Brindley PJ; Ittiprasert W
Neoplasia; 2020 May; 22(5):203-216. PubMed ID: 32244128
[TBL] [Abstract][Full Text] [Related]
33. Liver fluke-associated cholangiocarcinoma.
Watanapa P; Watanapa WB
Br J Surg; 2002 Aug; 89(8):962-70. PubMed ID: 12153620
[TBL] [Abstract][Full Text] [Related]
34. Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.
Hanpanich P; Laha T; Sripa B; Mairiang E; Sereerak P; Upontain S; Tangkawattana P; Brindley PJ; Tangkawattana S
Parasitol Int; 2017 Aug; 66(4):464-470. PubMed ID: 27143606
[TBL] [Abstract][Full Text] [Related]
35. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
Sudsarn P; Boonmars T; Ruangjirachuporn W; Namwat N; Loilome W; Sriraj P; Aukkanimart R; Nadchanan W; Jiraporn S
Pathol Oncol Res; 2016 Jan; 22(1):57-65. PubMed ID: 26277607
[TBL] [Abstract][Full Text] [Related]
36. Identification and functional analysis of mitogenic miRNA of the carcinogenic liver fluke Opisthorchis viverrini.
Tan S; Thanan R; Sripa B; Suttiprapa S
Acta Trop; 2024 Aug; 256():107243. PubMed ID: 38719083
[TBL] [Abstract][Full Text] [Related]
37. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group.
Silakit R; Loilome W; Yongvanit P; Thongchot S; Sithithaworn P; Boonmars T; Koonmee S; Titapun A; Khuntikeo N; Chamadol N; Techasen A; Namwat N
Parasitol Int; 2017 Aug; 66(4):479-485. PubMed ID: 26456596
[TBL] [Abstract][Full Text] [Related]
38. Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.
Wu Z; Boonmars T; Nagano I; Loilome W; Yongvanit P; Khuntikeo N; Nielsen PS; Paorojkul C; Takahashi Y; Maekawa Y
Tumour Biol; 2014 Mar; 35(3):1985-95. PubMed ID: 24122204
[TBL] [Abstract][Full Text] [Related]
39. Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma.
Thanasai J; Limpaiboon T; Jearanaikoon P; Bhudhisawasdi V; Khuntikeo N; Sripa B; Miwa M
World J Gastroenterol; 2006 Jul; 12(27):4338-44. PubMed ID: 16865775
[TBL] [Abstract][Full Text] [Related]
40. Specific serum IgG, but not IgA, antibody against purified Opisthorchis viverrini antigen associated with hepatobiliary disease and cholangiocarcinoma.
Pinlaor P; Pongsamart P; Hongsrichan N; Sangka A; Srilunchang T; Mairiang E; Sithithaworn P; Pinlaor S
Parasitol Int; 2012 Mar; 61(1):212-6. PubMed ID: 21718798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
